2023
Improvement in the Prediction of Cerebrovascular Events With White Matter Hyperintensity
de Havenon A, Smith E, Sharma R, Falcone G, Bangad A, Prabhakaran S, Sheth K. Improvement in the Prediction of Cerebrovascular Events With White Matter Hyperintensity. Journal Of The American Heart Association 2023, 12: e029374. PMID: 37345754, PMCID: PMC10356061, DOI: 10.1161/jaha.123.029374.Peer-Reviewed Original ResearchConceptsWhite matter hyperintensitiesIncident strokePrimary outcomeHypertensive individualsMatter hyperintensitiesAtherosclerotic cardiovascular disease risk scoreCognitive impairmentCardiovascular disease risk scoreVascular risk factorsCurrent cigarette smokingDisease risk scoreMagnetic resonance imagingLogistic regression modelsRandomization armCerebrovascular eventsVascular riskCigarette smokingPrognostic informationRisk factorsPrognostic abilityRisk scoreCognitive declineResonance imagingDeLong testStrokeUse of family history of cardiovascular disease or chronic hypertension to better identify who needs postpartum cardiovascular risk screening
Ackerman-Banks C, Pudwell J, Lundsberg L, Lipkind H, Smith G. Use of family history of cardiovascular disease or chronic hypertension to better identify who needs postpartum cardiovascular risk screening. American Journal Of Obstetrics & Gynecology MFM 2023, 5: 100850. PMID: 36640863, DOI: 10.1016/j.ajogmf.2022.100850.Peer-Reviewed Original ResearchConceptsPositive family historyFirst-degree family historyChronic hypertensionHypertensive disordersCardiovascular riskFamily historyCardiovascular diseaseUncomplicated pregnanciesControl individualsCardiovascular disease risk scoreBody mass indexDisease risk scoreFirst-degree relativesPregnancy complicationsTerm pregnancyMetabolic syndromeMass indexMyocardial infarctionHypertensionRisk scorePregnancyDiseaseIdentifies individualsDisordersRisk
2022
Performance Of The MELDXI Score In A Modern Left Ventricular Assist Device Cohort
Stawiarski K, Agboola O, Costantino A, Raskhe A, Bonde R, Bonde P. Performance Of The MELDXI Score In A Modern Left Ventricular Assist Device Cohort. Journal Of Cardiac Failure 2022, 28: s79-s80. DOI: 10.1016/j.cardfail.2022.03.201.Peer-Reviewed Original ResearchPost-operative adverse eventsMELD-XIAdverse eventsHigh riskCox proportional hazard ratiosLeft ventricular assist device placementRed blood cell transfusionVentricular assist device placementMELD-XI scorePerioperative transfusion requirementsPostoperative adverse eventsAdverse perioperative eventsBlood cell transfusionPost-operative bleedingProportional hazard ratiosDisease risk scoreKaplan-Meir plotsWilcoxon rank sum testLog-rank statisticsRank sum testDevice cohortLVAD candidatesTransfusion requirementsBaseline characteristicsCause mortality
2017
Cardiovascular disease risk among Chinese antiretroviral-naïve adults with advanced HIV disease
Guo F, Hsieh E, Lv W, Han Y, Xie J, Li Y, Song X, Li T. Cardiovascular disease risk among Chinese antiretroviral-naïve adults with advanced HIV disease. BMC Infectious Diseases 2017, 17: 287. PMID: 28427339, PMCID: PMC5397830, DOI: 10.1186/s12879-017-2358-0.Peer-Reviewed Original ResearchConceptsCVD risk factorsFramingham risk scoreRisk factorsRisk scoreCVD riskAtherosclerotic cardiovascular disease risk scoreCommon CVD risk factorsCardiovascular disease risk scoreAdvanced HIV diseaseD risk scoreTreatment-naïve HIVLipid-Lowering TherapyPrevalence of hypertensionRisk factor treatmentBurden of CVDCardiovascular disease riskTreatment-naïve individualsMulticenter clinical trialAntiretroviral-naïve adultsDisease risk scoreRoutine clinical assessmentHIV providersAdverse eventsBackgroundCardiovascular diseaseHIV disease
2016
Risk for Hospitalized Heart Failure Among New Users of Saxagliptin, Sitagliptin, and Other Antihyperglycemic Drugs: A Retrospective Cohort Study.
Toh S, Hampp C, Reichman ME, Graham DJ, Balakrishnan S, Pucino F, Hamilton J, Lendle S, Iyer A, Rucker M, Pimentel M, Nathwani N, Griffin MR, Brown NJ, Fireman BH. Risk for Hospitalized Heart Failure Among New Users of Saxagliptin, Sitagliptin, and Other Antihyperglycemic Drugs: A Retrospective Cohort Study. Annals Of Internal Medicine 2016, 164: 705-14. PMID: 27110660, PMCID: PMC5178978, DOI: 10.7326/m15-2568.Peer-Reviewed Original ResearchConceptsHospitalized heart failureMini-Sentinel programCohort studyHeart failureAntihyperglycemic agentsPropensity score-matched analysisDipeptidyl peptidase-4 inhibitorsNew-user cohort studyU.S. FoodPrior cardiovascular diseaseRetrospective cohort studyPeptidase-4 inhibitorsSubgroup of patientsPrincipal discharge diagnosisDPP-4 inhibitorsSecond-generation sulfonylureasType 2 diabetesLarge cohort studyDisease risk scoreSitagliptin usersStudy drugHazard ratioDischarge diagnosisNinth RevisionResidual confounding
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply